Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Andre S. Jung"'
Autor:
Scott D. Patterson, Roger Sidhu, Andre S. Jung, Jan-Henrik Terwey, Reija Koukakis, Hua Yu, Pei He, Eric Van Cutsem, Laslo Roman, Tudor E. Ciuleanu, Gregory Wilson, Andrew H. Strickland, Cornelis J.A. Punt, Florian Lordick, Emily Chan, Thierry André, Yevhen Hotko, Michel Ducreux, Alberto F. Sobrero, Andrés Cervantes, Timothy J. Price, Kelly S. Oliner, Marc Peeters
Contains: Table S1. RAS and BRAF Mutation Status Table S2. Objective Response Rate in Patients with Mutated RAS Table S3. Depth of Response and Early Tumor Response in Wild-type KRAS Exon 2 Patients Figure S1. Disposition of patients in the study and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a270e11af1fd12d264083118e64d68d8
https://doi.org/10.1158/1078-0432.22460478
https://doi.org/10.1158/1078-0432.22460478
Autor:
Scott D. Patterson, Roger Sidhu, Andre S. Jung, Jan-Henrik Terwey, Reija Koukakis, Hua Yu, Pei He, Eric Van Cutsem, Laslo Roman, Tudor E. Ciuleanu, Gregory Wilson, Andrew H. Strickland, Cornelis J.A. Punt, Florian Lordick, Emily Chan, Thierry André, Yevhen Hotko, Michel Ducreux, Alberto F. Sobrero, Andrés Cervantes, Timothy J. Price, Kelly S. Oliner, Marc Peeters
Purpose: We evaluated the influence of RAS mutation status on the treatment effect of panitumumab in a prospective–retrospective analysis of a randomized, multicenter phase III study of panitumumab plus fluorouracil, leucovorin, and irinotecan (FOL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::236fc56665240edab4fb993d5fdfdc8c
https://doi.org/10.1158/1078-0432.c.6524502
https://doi.org/10.1158/1078-0432.c.6524502